» Articles » PMID: 19173715

A Comprehensive Overview of Radioguided Surgery Using Gamma Detection Probe Technology

Overview
Publisher Biomed Central
Date 2009 Jan 29
PMID 19173715
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The concept of radioguided surgery, which was first developed some 60 years ago, involves the use of a radiation detection probe system for the intraoperative detection of radionuclides. The use of gamma detection probe technology in radioguided surgery has tremendously expanded and has evolved into what is now considered an established discipline within the practice of surgery, revolutionizing the surgical management of many malignancies, including breast cancer, melanoma, and colorectal cancer, as well as the surgical management of parathyroid disease. The impact of radioguided surgery on the surgical management of cancer patients includes providing vital and real-time information to the surgeon regarding the location and extent of disease, as well as regarding the assessment of surgical resection margins. Additionally, it has allowed the surgeon to minimize the surgical invasiveness of many diagnostic and therapeutic procedures, while still maintaining maximum benefit to the cancer patient. In the current review, we have attempted to comprehensively evaluate the history, technical aspects, and clinical applications of radioguided surgery using gamma detection probe technology.

Citing Articles

Use of Radioguided Surgery for Small and Difficult-to-Locate Relapsed MIBG (+) High-Risk Neuroblastoma Lesions.

Krauel L, Pasten A, Gorostegui M, Mane S, Martin Gimenez M, Coronas M Cancers (Basel). 2024; 16(19).

PMID: 39409967 PMC: 11475745. DOI: 10.3390/cancers16193348.


Infrared Fluorescence-guided Surgery for Tumor and Metastatic Lymph Node Detection in Head and Neck Cancer.

White H, Naveed A, Campbell B, Lee Y, Baik F, Topf M Radiol Imaging Cancer. 2024; 6(4):e230178.

PMID: 38940689 PMC: 11287229. DOI: 10.1148/rycan.230178.


Translocator Protein 18 kDa (TSPO): A Promising Molecular Target for Image-Guided Surgery of Solid Cancers.

Wongso H, Kurniawan A, Setiadi Y, Kusumaningrum C, Widyasari E, Wibawa T Adv Pharm Bull. 2024; 14(1):86-104.

PMID: 38585455 PMC: 10997928. DOI: 10.34172/apb.2024.015.


First-in-human validation of a DROP-IN β-probe for robotic radioguided surgery: defining optimal signal-to-background discrimination algorithm.

Collamati F, Morganti S, van Oosterom M, Campana L, Ceci F, Luzzago S Eur J Nucl Med Mol Imaging. 2024; 51(10):3098-3108.

PMID: 38376805 PMC: 11300660. DOI: 10.1007/s00259-024-06653-6.


Steerable DROP-IN radioguidance during minimal-invasive non-robotic cervical and endometrial sentinel lymph node surgery.

van Oosterom M, Diaz-Feijoo B, Santisteban M, Sanchez-Izquierdo N, Perissinotti A, Glickman A Eur J Nucl Med Mol Imaging. 2024; 51(10):3089-3097.

PMID: 38233608 PMC: 11300633. DOI: 10.1007/s00259-023-06589-3.


References
1.
Sortini D, Feo C, Carrella G, Bergossi L, Soliani G, Carcoforo P . Thoracoscopic localization techniques for patients with a single pulmonary nodule and positive oncological anamnesis: a prospective study. J Laparoendosc Adv Surg Tech A. 2004; 13(6):371-5. DOI: 10.1089/109264203322656432. View

2.
Povoski S, Olsen J, Young D, Clarke J, Burak W, Walker M . Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol. 2006; 13(11):1412-21. DOI: 10.1245/s10434-006-9022-z. View

3.
Haugen B . Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol. 1999; 16(1):34-41. DOI: 10.1002/(sici)1098-2388(199901/02)16:1<34::aid-ssu7>3.0.co;2-2. View

4.
Rzyman W, Hagen O, Dziadziuszko R, Kobierska-Gulida G, Karmolinski A, Lothe I . Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients. Ann Thorac Surg. 2006; 82(1):237-42. DOI: 10.1016/j.athoracsur.2006.01.094. View

5.
Gu J, Zhao J, Li Z, Yang Z, Zhang J, Gao Z . Clinical application of radioimmunoguided surgery in colorectal cancer using 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally. Dis Colon Rectum. 2003; 46(12):1659-66. DOI: 10.1007/BF02660772. View